Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Clinical trial NCT00151073 · COMPLETED

Trial details

NCT number: NCT00151073
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Refractory Prostate Cancer

Start date: 2002-04-01
Primary completion: 2005-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.